CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
41 hedge funds and large institutions have $46.3M invested in Cyteir Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.24M | |
| 2 | +$3.05M | |
| 3 | +$1.26M | |
| 4 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$1.18M |
| 5 |
Walleye Capital
New York
|
+$1.01M |
Top Sellers
| 1 | -$8.48M | |
| 2 | -$1.36M | |
| 3 | -$399K | |
| 4 |
EWM
Evercore Wealth Management
New York
|
-$381K |
| 5 |
Renaissance Technologies
New York
|
-$99.8K |